Zhang D, Liu BW, Liang XQ, Liu FQ. Immunological factors in cirrhosis diseases from a bibliometric point of view. World J Gastroenterol 2023; 29(24): 3899-3921 [PMID: 37426317 DOI: 10.3748/wjg.v29.i24.3899]
Corresponding Author of This Article
Fu-Quan Liu, MM, Chief Doctor, Doctor, Professor, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, No. 10 Tieyi Road, Yangfangdian Street, Haidian District, Beijing 100038, China. liufuquan@ccmu.edu.cn
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Scientometrics
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jun 28, 2023; 29(24): 3899-3921 Published online Jun 28, 2023. doi: 10.3748/wjg.v29.i24.3899
Table 1 Publications in the 10 most productive countries/regions
Rank
Country/region
Year
Count (%)
Centrality
1
United States
2003
781 (27.18%)
0.36
2
China
2003
538 (18.73%)
0.06
3
Germany
2003
300 (10.44%)
0.17
4
Italy
2003
259 (9.01%)
0.19
5
Japan
2003
192 (6.68%)
0.03
6
England
2003
186 (6.47%)
0.20
7
Spain
2003
157 (5.46%)
0.09
8
France
2003
132 (4.59%)
0.17
9
Australia
2004
85 (2.96%)
0.12
10
Canada
2003
84 (2.92%)
0.12
Table 2 Publications in the 10 most productive institutions
Rank
Institution
Year
Count (%)
Centrality
1
Univ Calif Davis (United States)
2004
65 (2.26%)
0.12
2
Mayo Clin (United States)
2007
47 (1.64%)
0.02
3
Zhejiang Univ (China)
2011
44 (1.53%)
0.01
4
Univ Birmingham (England)
2009
38 (1.32%)
0.04
5
Univ Calif San Diego (United States)
2009
28 (0.97%)
0.07
6
Yale Univ (United States)
2007
26 (0.90%)
0.06
7
Inst Salud Carlos III (Spain)
2008
25 (0.87%)
0.06
8
Univ Milan (Italy)
2004
24 (0.84%)
0.06
9
Univ Barcelona (Spain)
2003
23 (0.80%)
0.03
10
Emory Univ (United States)
2006
23 (0.80%)
0.05
Table 3 Top 10 authors and co-cited authors
Rank
Author
Count (%)
Centrality
Co-cited author
Co-citation
Centrality
1
Gershwin M Eric (United States)
42 (1.46%)
0.02
Friedman Scott L (United States)
337
0.05
2
Tacke Frank (Germany)
27 (0.94%)
0.01
Bataller Ramon (United States)
235
0.06
3
Trautwein Christian (Germany)
20 (0.70%)
0.01
Seki Ekihiro (United States)
204
0.05
4
Weiskirchen Ralf (Germany)
13 (0.45%)
0
Tilg Herbert (Austria)
141
0.07
5
Hirschfield Gideon M (Canada)
11 (0.38%)
0.01
Wynn Tomas A (United States)
140
0.02
6
Friedman Scott L (United States)
9 (0.31%)
0
Albillos Agustín (Spain)
128
0.01
7
Such Jose (Spain)
9 (0.31%)
0
Szabo Gyongyi (United States)
126
0.04
8
Szabo Gyongyi (United States)
8 (0.28%)
0
Gao Bin (United States)
125
0.08
9
Invernizzi Pietro (Italy)
8 (0.28%)
0
Hirschfield Gideon M (Canada)
120
0.09
10
Czaja Albert J (United States)
8 (0.28%)
0
Li J (China)
116
0.02
Table 4 Top 10 journals and co-cited journals for research of immunological factors in cirrhosis
Rank
Journal
Count (%)
IF (2021)
JCR
Co-cited Journal
Citation
IF (2021)
JCR
1
World Journal of Gastroenterology
113 (3.928%)
5.374
Q2
Hepatology
2409
17.298
Q1
2
Hepatology
109 (3.790%)
17.298
Q1
Journal of Hepatology
2124
30.083
Q1
3
Frontiers in immunology
73 (2.540%)
8.786
Q1
Gastroenterology
1988
33.883
Q1
4
Journal of Hepatology
70 (2.430%)
30.083
Q1
Gut
1369
31.793
Q1
5
Liver International
59 (2.050%)
8.754
Q1
Journal Of Clinical Investigation
1301
19.456
Q1
6
PLoS One
57 (1.980%)
3.752
Q2
Journal Of Immunology
1280
5.426
Q2
7
International Journal of Molecular Sciences
46 (1.600%)
6.208
Q1
The New England Journal of Medicine
1240
176.079
Q1
8
Gastroenterology
35 (1.220%)
33.883
Q1
Proceedings of the National Academy of Sciences of the United States of America
1221
12.779
Q1
9
Seminars in Liver Disease
32 (1.110%)
6.512
Q2
PLoS One
1183
3.752
Q2
10
Hepatology Research
30 (1.040%)
4.942
Q2
Lancet
1153
202.731
Q1
Table 5 Top 10 co-cited references on research of immunological factors in cirrhosis
Rank
Reference
Year
Journal
Citation
Centrality
1
Mechanisms of hepatic stellate cell activation
2017
Nature Reviews Gastroenterology & Hepatology
50
0.03
2
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014
Journal of Hepatology
46
0.02
3
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017
Journal of Hepatology
35
0.03
4
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
2013
Gastroenterology
35
0.03
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018
CA: A Cancer Journal for Clinicians
33
0.02
6
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial
2017
Lancet
33
0.04
7
Immunology in the liver-from homeostasis to disease
2016
Nature Reviews Gastroenterology & Hepatology
32
0.14
8
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure
2016
Hepatology
31
0.07
9
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants
2009
The New England Journal of Medicine
31
0.02
10
TLR4 enhances TGF-beta signaling and hepatic fibrosis
2007
Nature Medicine
31
0.06
Table 6 Top 20 keywords on research of immunological factors in cirrhosis
Rank
Keyword
Occurrences
Total link strength
Rank
Keyword
Occurrences
Total link strength
1
Fibrosis
428
2558
11
Liver
225
1276
2
Cirrhosis
423
2483
12
Risk factors
221
1200
3
Inflammation
384
2438
13
Infection
184
1123
4
Liver fibrosis
381
2290
14
Necrosis factor alpha
160
1001
5
Expression
340
1884
15
T cells
155
923
6
Hepatocellular carcinoma
309
1895
16
Cells
143
770
7
Activation
234
1421
17
Regulatory t cells
140
863
8
Primary biliary cirrhosis
232
1268
18
Liver cirrhosis
133
770
9
Disease
231
1355
19
Growth factor beta
130
834
10
Hepatic stellate cells
228
1525
20
Oxidative stress
129
836
Citation: Zhang D, Liu BW, Liang XQ, Liu FQ. Immunological factors in cirrhosis diseases from a bibliometric point of view. World J Gastroenterol 2023; 29(24): 3899-3921